Programme overview (subject to change)

Size: px

Start display at page:

Download "Programme overview (subject to change)"

Ashley Potter
5 years ago
Views:

Programme overview (subject to change) Time 0800-0900 Premiminary programme - Thursday 7 June Olavshallen 1204 seats Olav Tryggvasson 325 seats Haraldsalen 140 seats Tavern/ Brattøra 210 seats

1 Programme overview (subject to change) Time Premiminary programme - Thursday 7 June Olavshallen 1204 seats Olav Tryggvasson 325 seats Haraldsalen 140 seats Tavern/ Brattøra 210 seats Registration and informal meetings Opening ceremony Welcomes Eduardo Bruera: Findings and impact over 25 years Selected abstract (1) Selected abstract (2) Selected abstract (3) Lunch Satellite symposium: Astellas Lunch Lunch Company sponsored satellite symposium (1) session (1): Cancer cachexia Coffee break session (2): Junior Forum (3) (4) Research project: ATOME Lillesalen 350 seats (2) session (3): EAPC RN Cicignon viewing 2000 Get together 1 of 6

2 Preliminary programme Friday 8 June Time Olavshallen 1204 seats Olav Tryggvasson 325 seats Opioid addiction Plenary session Gary Rodin: Scientific contribution of psychosocial factors in palliative care Selected abstract (4) Selected abstract (5 = ERA) Haraldsalen 140 seats How to read and write papers Tavern/ Brattøra 210 seats Transitions in the end of life Coffee break and poster viewing Company sponsored satellite symposium (5) discussion session Lunch/poster viewing Satellite Lunch/poster viewing symposium: ProStrakan Lunch/poster viewing (6) (7) (8) Coffee break and poster viewing (9) (10) (11) Lillesalen 350 seats Polypharmacy session (4): Research in action: from policy to practice and back session (5): Palliative sedation session (6): Cognitive impairment Cicignon viewing 1900 Concert, Nidarosdomen 2 of 6

3 Preliminary programme - Saturday 9 June Time Olavshallen 1204 seats Olav Tryggvasson 325 seats Place of death in Europe (12) Haraldsalen 140 seats Palliative care indicators session (7): Cancer pain classification Tavern/ Brattøra 210 seats Timing of palliative care (13) Coffee break and poster viewing session (8): Studying palliative care in dementia patients (14) (15) Lunch and poster viewing Plenary session Irene Higginson: Factors and future trends in research on place of death Selected abstract (6) Closing ceremony Lillesalen 350 seats Sustainable research collaboration discussion session (16) Cicignon viewing 3 of 6

4 Plenary sessions: 1. The development of a research field over 25 years: Most important findings and their impact. Eduardo Bruera, USA 2. Research on psychological and social factors in palliative care: contributions, controversies and impact on the field. Gary Rodin, Canada 3. Dying at home is it better: what have we learned and where are we going? Irene Higginson, UK sessions: 1. Cancer cachexia a. Definition and classification of cancer cachexia: heading for an international consensus? Ken Fearon (UK) b. The evidence for nutritional support in multimodal therapy for cancer cachexia. Ingvar Bosaeus (Sweden) c. Pathophysiology of cachexia. Common features in cancer and COPD? Annemie Schols (Netherlands) 2. Junior Forum a. Don t miss out: Managing missing data. Peter Fayers (UK) b. Using an inductive research approach: A transcontinental study. Christopher Klinger (Germany) c. All mixed up? Using mixed methodology to evaluate complex interventions. Jonathan Koffman (UK) 3. EAPC Research Network a. Status today of public health and health-services research. Luc Deliens (Belgium), 15 min b. Status today of clinical studies. Stein Kaasa (Norway), 15 min c. Basic research: how to plan and collaborate. Marie Fallon (UK), 15 min d. How to set the future research agenda of clinical research. Lukas Radbruch (Germany), 10 min e. How to set the future research agenda of health-services research. Sheila Payne (UK), 10 min f. Discussion, 25 min 4. Research in action: from policy to practice and back a. Addressing the complexity of policy implementation: evaluations of the NHS End of Life Care Programme. Jane Seymour (UK) b. Research into practice in the USA: emotive and misleading or good science? Sean Morrison (USA) c. Changing medication access policy in Eastern Europe: state of confusion? Daniella Mosoiu (Romania) 5. Palliative sedation: state of the art research findings a. Clinical and epidemiological research in palliative sedation: how has it served physicians till now and what should we expect for the future. A review of the literature. Guido Miccinesi (Italy) 4 of 6

5 b. Nurses beliefs, attitudes and behaviours in palliative sedation: evidence from a multicentre study in the UK. Jayne Brown (UK) c. Family-centered end-of-life care? Experiences of relatives with palliative sedation. Agnes van der Heide (Netherlands) 6. Cognitive impairment a. How to assess cognitive functioning in advanced disease? Cognitive domains, tools and trials. Geana Kurita (Denmark) b. The cognitive effects of opioids. Pål Klepstad (Norway) c. The cognitive effects of symptoms and co-morbidities in advanced cancer. Speaker to be confirmed 7. Cancer pain classification a. Is there a need for a comprehensive classification of cancer pain? Mike Bennett (UK) b. Detecting key variables for cancer pain classification. Anne Kari Knudsen (Norway) c. Validation of a pain classification system for cancer patients. Robin Fainsinger (Canada) 8. Studying palliative care in dementia patients a. How effective is a family booklet about comfort care in advanced dementia? A study in 3 countries. Marcel Arcand (Canada) b. End-of-life care and quality of dying of people with dementia: a nationwide study. Lieve Van den Block (Belgium) c. Retrospective versus prospective assessment and process versus outcome measures in studying palliative care needs in patients with dementia. Jenny van der Steen (The Netherlands) Meet-the-expert sessions 1. Does opioid addiction play a role in advanced cancer? (Sebastiano Mercadante/Eduardo Bruera) 2. How to write and read a paper (Geoffrey Hanks/Luc Deliens) 3. Transitions in the end of life (Mike Bennett/Dagny Faksvåg Haugen) 4. Polypharmacy: What is the evidence? (Pål Klepstad/To be confirmed) 5. Why does place of death vary between European countries, and how to understand and study the variation? (Peter Lawlor/Irene Higginsson) 6. Quality indicators/palliative care indicators (David Currow/Lieve Van den Block) 7. When is the right time to start palliative care? (Robin Fainsinger/Sean Morrison) 8. How to build sustainable research collaboration (Eduardo Bruera/Stein Kaasa). sessions 5 of 6

6 16 sessions with submitted abstracts 6 of 6

END-OF-LIFE CARE RESEARCH GROUP

END-OF-LIFE CARE RESEARCH GROUP ACHIEVING THE BEST PALLIATIVE AND END-OF-LIFE CARE Director Prof. dr. Luc Deliens The 10th EAPC World Congress is a special edition for the End-of-Life Care Research Group.